Index by author

August 15, 2022; Volume 19,Issue 8

B

  1. Bai, Weiyu

    1. PYK2 mediates the BRAF inhibitor (vermurafenib)-induced invadopodia formation and metastasis in melanomas
      Junling Shen, Jilong Yang, Lei Sang, Rui Sun, Weiyu Bai, Chao Wang, Yan Sun and Jianwei Sun
      Cancer Biology & Medicine August 2022, 19 (8) 1211-1223; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0294

  2. Bai, Wenqi

    1. Lynch syndrome pre-screening and comprehensive characterization in a multi-center large cohort of Chinese patients with colorectal cancer
      Yan Li, Lihong Fan, Jianming Zheng, Xiu Nie, Yu Sun, Qin Feng, Shenyi Lian, Wenqi Bai, Weijing Cai, Yanan Yang, Bo Su, Yanfeng Xi and Dongmei Lin
      Cancer Biology & Medicine August 2022, 19 (8) 1235-1248; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0585

C

  1. Cai, Weijing

    1. Lynch syndrome pre-screening and comprehensive characterization in a multi-center large cohort of Chinese patients with colorectal cancer
      Yan Li, Lihong Fan, Jianming Zheng, Xiu Nie, Yu Sun, Qin Feng, Shenyi Lian, Wenqi Bai, Weijing Cai, Yanan Yang, Bo Su, Yanfeng Xi and Dongmei Lin
      Cancer Biology & Medicine August 2022, 19 (8) 1235-1248; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0585

  2. Cai, Wenli

    1. Loss of NEIL3 activates radiotherapy resistance in the progression of prostate cancer
      Qiong Wang, Zean Li, Jin Yang, Shirong Peng, Qianghua Zhou, Kai Yao, Wenli Cai, Zhongqiu Xie, Fujun Qin, Hui Li, Xu Chen, Kaiwen Li and Hai Huang
      Cancer Biology & Medicine August 2022, 19 (8) 1193-1210; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0550

  3. Cao, Maomao

    1. Current cancer burden in China: epidemiology, etiology, and prevention
      Maomao Cao, He Li, Dianqin Sun, Siyi He, Xinxin Yan, Fan Yang, Shaoli Zhang, Changfa Xia, Lin Lei, Ji Peng and Wanqing Chen
      Cancer Biology & Medicine August 2022, 19 (8) 1121-1138; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0231

  4. Chen, Chong

    1. Epigenetic reprogramming in small cell lung cancer
      Jingyao Chen, Xiangyu Pan, Feifei Na, Xuelan Chen and Chong Chen
      Cancer Biology & Medicine August 2022, 19 (8) 1111-1116; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0343

  5. Chen, Huan

    1. Alterations in DNA damage response and repair genes as potential biomarkers for immune checkpoint blockade in gastrointestinal cancer
      Yujiao Wang, Xi Jiao, Shuang Li, Huan Chen, Xin Wei, Chang Liu, Jifang Gong, Xiaotian Zhang, Xicheng Wang, Zhi Peng, Changsong Qi, Zhenghang Wang, Yanni Wang, Na Zhuo, Jianling Zou, Henghui Zhang, Jian Li, Lin Shen and Zhihao Lu
      Cancer Biology & Medicine August 2022, 19 (8) 1139-1149; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0708

  6. Chen, Jingyao

    1. Epigenetic reprogramming in small cell lung cancer
      Jingyao Chen, Xiangyu Pan, Feifei Na, Xuelan Chen and Chong Chen
      Cancer Biology & Medicine August 2022, 19 (8) 1111-1116; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0343

  7. Chen, Wanqing

    1. Current cancer burden in China: epidemiology, etiology, and prevention
      Maomao Cao, He Li, Dianqin Sun, Siyi He, Xinxin Yan, Fan Yang, Shaoli Zhang, Changfa Xia, Lin Lei, Ji Peng and Wanqing Chen
      Cancer Biology & Medicine August 2022, 19 (8) 1121-1138; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0231

  8. Chen, Xinrui

    1. Update on diffuse large B-cell lymphoma: highlights from the 2022 ASCO Annual Meeting
      Minghan Qiu, Shan Wu, Xinrui Chen and Huaqing Wang
      Cancer Biology & Medicine August 2022, 19 (8) 1117-1120; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0403

  9. Chen, Xu

    1. Loss of NEIL3 activates radiotherapy resistance in the progression of prostate cancer
      Qiong Wang, Zean Li, Jin Yang, Shirong Peng, Qianghua Zhou, Kai Yao, Wenli Cai, Zhongqiu Xie, Fujun Qin, Hui Li, Xu Chen, Kaiwen Li and Hai Huang
      Cancer Biology & Medicine August 2022, 19 (8) 1193-1210; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0550

  10. Chen, Xuelan

    1. Epigenetic reprogramming in small cell lung cancer
      Jingyao Chen, Xiangyu Pan, Feifei Na, Xuelan Chen and Chong Chen
      Cancer Biology & Medicine August 2022, 19 (8) 1111-1116; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0343

  11. Chen, Yi

    1. The HDAC inhibitor GCJ-490A suppresses c-Met expression through IKKα and overcomes gefitinib resistance in non-small cell lung cancer
      Ting He, Yinglei Gao, Yanfen Fang, Yangming Zhang, Shuwei Zhang, Fajun Nan, Jian Ding and Yi Chen
      Cancer Biology & Medicine August 2022, 19 (8) 1172-1192; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0130

  12. Cheng, Ying

    1. Peripheral blood indices to predict PFS/OS with anlotinib as a subsequent treatment in advanced small-cell lung cancer
      Cuicui Zhang, Jing Wang, Xinyue Wang, Zhaoting Meng, Ying Cheng and Kai Li
      Cancer Biology & Medicine August 2022, 19 (8) 1249-1258; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0727

D

  1. de la Torre, Katherine

    1. Frequent low dose alcohol intake increases gastric cancer risk: the Health Examinees-Gem (HEXA-G) study
      Hwi-Won Lee, Dan Huang, Woo-Kyoung Shin, Katherine de la Torre, Minkyo Song, Aesun Shin, Jong-Koo Lee and Daehee Kang
      Cancer Biology & Medicine August 2022, 19 (8) 1224-1234; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0642

  2. Ding, Jian

    1. The HDAC inhibitor GCJ-490A suppresses c-Met expression through IKKα and overcomes gefitinib resistance in non-small cell lung cancer
      Ting He, Yinglei Gao, Yanfen Fang, Yangming Zhang, Shuwei Zhang, Fajun Nan, Jian Ding and Yi Chen
      Cancer Biology & Medicine August 2022, 19 (8) 1172-1192; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0130

  3. Du, Liqing

    1. BLM helicase inhibition synergizes with PARP inhibition to improve the radiosensitivity of olaparib resistant non-small cell lung cancer cells by inhibiting homologous recombination repair
      Yangyang Kong, Chang Xu, Xiaohui Sun, Hao Sun, Xiaotong Zhao, Ningning He, Kaihua Ji, Qin Wang, Liqing Du, Jinhan Wang, Manman Zhang, Yang Liu, Yan Wang and Qiang Liu
      Cancer Biology & Medicine August 2022, 19 (8) 1150-1171; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0178

F

  1. Fan, Lihong

    1. Lynch syndrome pre-screening and comprehensive characterization in a multi-center large cohort of Chinese patients with colorectal cancer
      Yan Li, Lihong Fan, Jianming Zheng, Xiu Nie, Yu Sun, Qin Feng, Shenyi Lian, Wenqi Bai, Weijing Cai, Yanan Yang, Bo Su, Yanfeng Xi and Dongmei Lin
      Cancer Biology & Medicine August 2022, 19 (8) 1235-1248; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0585

  2. Fang, Yanfen

    1. The HDAC inhibitor GCJ-490A suppresses c-Met expression through IKKα and overcomes gefitinib resistance in non-small cell lung cancer
      Ting He, Yinglei Gao, Yanfen Fang, Yangming Zhang, Shuwei Zhang, Fajun Nan, Jian Ding and Yi Chen
      Cancer Biology & Medicine August 2022, 19 (8) 1172-1192; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0130

  3. Feng, Qin

    1. Lynch syndrome pre-screening and comprehensive characterization in a multi-center large cohort of Chinese patients with colorectal cancer
      Yan Li, Lihong Fan, Jianming Zheng, Xiu Nie, Yu Sun, Qin Feng, Shenyi Lian, Wenqi Bai, Weijing Cai, Yanan Yang, Bo Su, Yanfeng Xi and Dongmei Lin
      Cancer Biology & Medicine August 2022, 19 (8) 1235-1248; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0585

G

  1. Gao, Yinglei

    1. The HDAC inhibitor GCJ-490A suppresses c-Met expression through IKKα and overcomes gefitinib resistance in non-small cell lung cancer
      Ting He, Yinglei Gao, Yanfen Fang, Yangming Zhang, Shuwei Zhang, Fajun Nan, Jian Ding and Yi Chen
      Cancer Biology & Medicine August 2022, 19 (8) 1172-1192; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0130

  2. Gong, Jifang

    1. Alterations in DNA damage response and repair genes as potential biomarkers for immune checkpoint blockade in gastrointestinal cancer
      Yujiao Wang, Xi Jiao, Shuang Li, Huan Chen, Xin Wei, Chang Liu, Jifang Gong, Xiaotian Zhang, Xicheng Wang, Zhi Peng, Changsong Qi, Zhenghang Wang, Yanni Wang, Na Zhuo, Jianling Zou, Henghui Zhang, Jian Li, Lin Shen and Zhihao Lu
      Cancer Biology & Medicine August 2022, 19 (8) 1139-1149; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0708

H

  1. He, Ningning

    1. BLM helicase inhibition synergizes with PARP inhibition to improve the radiosensitivity of olaparib resistant non-small cell lung cancer cells by inhibiting homologous recombination repair
      Yangyang Kong, Chang Xu, Xiaohui Sun, Hao Sun, Xiaotong Zhao, Ningning He, Kaihua Ji, Qin Wang, Liqing Du, Jinhan Wang, Manman Zhang, Yang Liu, Yan Wang and Qiang Liu
      Cancer Biology & Medicine August 2022, 19 (8) 1150-1171; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0178

  2. He, Siyi

    1. Current cancer burden in China: epidemiology, etiology, and prevention
      Maomao Cao, He Li, Dianqin Sun, Siyi He, Xinxin Yan, Fan Yang, Shaoli Zhang, Changfa Xia, Lin Lei, Ji Peng and Wanqing Chen
      Cancer Biology & Medicine August 2022, 19 (8) 1121-1138; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0231

  3. He, Ting

    1. The HDAC inhibitor GCJ-490A suppresses c-Met expression through IKKα and overcomes gefitinib resistance in non-small cell lung cancer
      Ting He, Yinglei Gao, Yanfen Fang, Yangming Zhang, Shuwei Zhang, Fajun Nan, Jian Ding and Yi Chen
      Cancer Biology & Medicine August 2022, 19 (8) 1172-1192; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0130

  4. Huang, Dan

    1. Frequent low dose alcohol intake increases gastric cancer risk: the Health Examinees-Gem (HEXA-G) study
      Hwi-Won Lee, Dan Huang, Woo-Kyoung Shin, Katherine de la Torre, Minkyo Song, Aesun Shin, Jong-Koo Lee and Daehee Kang
      Cancer Biology & Medicine August 2022, 19 (8) 1224-1234; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0642

  5. Huang, Hai

    1. Loss of NEIL3 activates radiotherapy resistance in the progression of prostate cancer
      Qiong Wang, Zean Li, Jin Yang, Shirong Peng, Qianghua Zhou, Kai Yao, Wenli Cai, Zhongqiu Xie, Fujun Qin, Hui Li, Xu Chen, Kaiwen Li and Hai Huang
      Cancer Biology & Medicine August 2022, 19 (8) 1193-1210; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0550

J

  1. Ji, Kaihua

    1. BLM helicase inhibition synergizes with PARP inhibition to improve the radiosensitivity of olaparib resistant non-small cell lung cancer cells by inhibiting homologous recombination repair
      Yangyang Kong, Chang Xu, Xiaohui Sun, Hao Sun, Xiaotong Zhao, Ningning He, Kaihua Ji, Qin Wang, Liqing Du, Jinhan Wang, Manman Zhang, Yang Liu, Yan Wang and Qiang Liu
      Cancer Biology & Medicine August 2022, 19 (8) 1150-1171; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0178

  2. Jiao, Xi

    1. Alterations in DNA damage response and repair genes as potential biomarkers for immune checkpoint blockade in gastrointestinal cancer
      Yujiao Wang, Xi Jiao, Shuang Li, Huan Chen, Xin Wei, Chang Liu, Jifang Gong, Xiaotian Zhang, Xicheng Wang, Zhi Peng, Changsong Qi, Zhenghang Wang, Yanni Wang, Na Zhuo, Jianling Zou, Henghui Zhang, Jian Li, Lin Shen and Zhihao Lu
      Cancer Biology & Medicine August 2022, 19 (8) 1139-1149; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0708

K

  1. Kang, Daehee

    1. Frequent low dose alcohol intake increases gastric cancer risk: the Health Examinees-Gem (HEXA-G) study
      Hwi-Won Lee, Dan Huang, Woo-Kyoung Shin, Katherine de la Torre, Minkyo Song, Aesun Shin, Jong-Koo Lee and Daehee Kang
      Cancer Biology & Medicine August 2022, 19 (8) 1224-1234; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0642

  2. Kong, Yangyang

    1. BLM helicase inhibition synergizes with PARP inhibition to improve the radiosensitivity of olaparib resistant non-small cell lung cancer cells by inhibiting homologous recombination repair
      Yangyang Kong, Chang Xu, Xiaohui Sun, Hao Sun, Xiaotong Zhao, Ningning He, Kaihua Ji, Qin Wang, Liqing Du, Jinhan Wang, Manman Zhang, Yang Liu, Yan Wang and Qiang Liu
      Cancer Biology & Medicine August 2022, 19 (8) 1150-1171; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0178

L

  1. Lee, Hwi-Won

    1. Frequent low dose alcohol intake increases gastric cancer risk: the Health Examinees-Gem (HEXA-G) study
      Hwi-Won Lee, Dan Huang, Woo-Kyoung Shin, Katherine de la Torre, Minkyo Song, Aesun Shin, Jong-Koo Lee and Daehee Kang
      Cancer Biology & Medicine August 2022, 19 (8) 1224-1234; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0642

  2. Lee, Jong-Koo

    1. Frequent low dose alcohol intake increases gastric cancer risk: the Health Examinees-Gem (HEXA-G) study
      Hwi-Won Lee, Dan Huang, Woo-Kyoung Shin, Katherine de la Torre, Minkyo Song, Aesun Shin, Jong-Koo Lee and Daehee Kang
      Cancer Biology & Medicine August 2022, 19 (8) 1224-1234; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0642

  3. Lei, Lin

    1. Current cancer burden in China: epidemiology, etiology, and prevention
      Maomao Cao, He Li, Dianqin Sun, Siyi He, Xinxin Yan, Fan Yang, Shaoli Zhang, Changfa Xia, Lin Lei, Ji Peng and Wanqing Chen
      Cancer Biology & Medicine August 2022, 19 (8) 1121-1138; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0231

  4. Li, He

    1. Current cancer burden in China: epidemiology, etiology, and prevention
      Maomao Cao, He Li, Dianqin Sun, Siyi He, Xinxin Yan, Fan Yang, Shaoli Zhang, Changfa Xia, Lin Lei, Ji Peng and Wanqing Chen
      Cancer Biology & Medicine August 2022, 19 (8) 1121-1138; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0231

  5. Li, Hui

    1. Loss of NEIL3 activates radiotherapy resistance in the progression of prostate cancer
      Qiong Wang, Zean Li, Jin Yang, Shirong Peng, Qianghua Zhou, Kai Yao, Wenli Cai, Zhongqiu Xie, Fujun Qin, Hui Li, Xu Chen, Kaiwen Li and Hai Huang
      Cancer Biology & Medicine August 2022, 19 (8) 1193-1210; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0550

  6. Li, Jian

    1. Alterations in DNA damage response and repair genes as potential biomarkers for immune checkpoint blockade in gastrointestinal cancer
      Yujiao Wang, Xi Jiao, Shuang Li, Huan Chen, Xin Wei, Chang Liu, Jifang Gong, Xiaotian Zhang, Xicheng Wang, Zhi Peng, Changsong Qi, Zhenghang Wang, Yanni Wang, Na Zhuo, Jianling Zou, Henghui Zhang, Jian Li, Lin Shen and Zhihao Lu
      Cancer Biology & Medicine August 2022, 19 (8) 1139-1149; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0708

  7. Li, Kai

    1. Peripheral blood indices to predict PFS/OS with anlotinib as a subsequent treatment in advanced small-cell lung cancer
      Cuicui Zhang, Jing Wang, Xinyue Wang, Zhaoting Meng, Ying Cheng and Kai Li
      Cancer Biology & Medicine August 2022, 19 (8) 1249-1258; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0727

  8. Li, Kaiwen

    1. Loss of NEIL3 activates radiotherapy resistance in the progression of prostate cancer
      Qiong Wang, Zean Li, Jin Yang, Shirong Peng, Qianghua Zhou, Kai Yao, Wenli Cai, Zhongqiu Xie, Fujun Qin, Hui Li, Xu Chen, Kaiwen Li and Hai Huang
      Cancer Biology & Medicine August 2022, 19 (8) 1193-1210; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0550

  9. Li, Qiang

    1. Prospective study of the effect of ERAS on postoperative recovery and complications in patients with gastric cancer
      Ye Tian, Qiang Li and Yuan Pan
      Cancer Biology & Medicine August 2022, 19 (8) 1274-1281; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0108

  10. Li, Shuang

    1. Alterations in DNA damage response and repair genes as potential biomarkers for immune checkpoint blockade in gastrointestinal cancer
      Yujiao Wang, Xi Jiao, Shuang Li, Huan Chen, Xin Wei, Chang Liu, Jifang Gong, Xiaotian Zhang, Xicheng Wang, Zhi Peng, Changsong Qi, Zhenghang Wang, Yanni Wang, Na Zhuo, Jianling Zou, Henghui Zhang, Jian Li, Lin Shen and Zhihao Lu
      Cancer Biology & Medicine August 2022, 19 (8) 1139-1149; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0708

  11. Li, Wenqing

    1. Effects of Helicobacter pylori eradication on the profiles of blood metabolites and their associations with the progression of gastric lesions: a prospective follow-up study
      Wenhui Wu, Zongchao Liu, Zhexuan Li, Weidong Liu, Lanfu Zhang, Yang Zhang, Tong Zhou, Weicheng You, Kaifeng Pan and Wenqing Li
      Cancer Biology & Medicine August 2022, 19 (8) 1259-1273; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0255

  12. Li, Yan

    1. Lynch syndrome pre-screening and comprehensive characterization in a multi-center large cohort of Chinese patients with colorectal cancer
      Yan Li, Lihong Fan, Jianming Zheng, Xiu Nie, Yu Sun, Qin Feng, Shenyi Lian, Wenqi Bai, Weijing Cai, Yanan Yang, Bo Su, Yanfeng Xi and Dongmei Lin
      Cancer Biology & Medicine August 2022, 19 (8) 1235-1248; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0585

  13. Li, Zean

    1. Loss of NEIL3 activates radiotherapy resistance in the progression of prostate cancer
      Qiong Wang, Zean Li, Jin Yang, Shirong Peng, Qianghua Zhou, Kai Yao, Wenli Cai, Zhongqiu Xie, Fujun Qin, Hui Li, Xu Chen, Kaiwen Li and Hai Huang
      Cancer Biology & Medicine August 2022, 19 (8) 1193-1210; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0550

  14. Li, Zhexuan

    1. Effects of Helicobacter pylori eradication on the profiles of blood metabolites and their associations with the progression of gastric lesions: a prospective follow-up study
      Wenhui Wu, Zongchao Liu, Zhexuan Li, Weidong Liu, Lanfu Zhang, Yang Zhang, Tong Zhou, Weicheng You, Kaifeng Pan and Wenqing Li
      Cancer Biology & Medicine August 2022, 19 (8) 1259-1273; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0255

  15. Lian, Shenyi

    1. Lynch syndrome pre-screening and comprehensive characterization in a multi-center large cohort of Chinese patients with colorectal cancer
      Yan Li, Lihong Fan, Jianming Zheng, Xiu Nie, Yu Sun, Qin Feng, Shenyi Lian, Wenqi Bai, Weijing Cai, Yanan Yang, Bo Su, Yanfeng Xi and Dongmei Lin
      Cancer Biology & Medicine August 2022, 19 (8) 1235-1248; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0585

  16. Lin, Dongmei

    1. Lynch syndrome pre-screening and comprehensive characterization in a multi-center large cohort of Chinese patients with colorectal cancer
      Yan Li, Lihong Fan, Jianming Zheng, Xiu Nie, Yu Sun, Qin Feng, Shenyi Lian, Wenqi Bai, Weijing Cai, Yanan Yang, Bo Su, Yanfeng Xi and Dongmei Lin
      Cancer Biology & Medicine August 2022, 19 (8) 1235-1248; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0585

  17. Liu, Chang

    1. Alterations in DNA damage response and repair genes as potential biomarkers for immune checkpoint blockade in gastrointestinal cancer
      Yujiao Wang, Xi Jiao, Shuang Li, Huan Chen, Xin Wei, Chang Liu, Jifang Gong, Xiaotian Zhang, Xicheng Wang, Zhi Peng, Changsong Qi, Zhenghang Wang, Yanni Wang, Na Zhuo, Jianling Zou, Henghui Zhang, Jian Li, Lin Shen and Zhihao Lu
      Cancer Biology & Medicine August 2022, 19 (8) 1139-1149; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0708

  18. Liu, Qiang

    1. BLM helicase inhibition synergizes with PARP inhibition to improve the radiosensitivity of olaparib resistant non-small cell lung cancer cells by inhibiting homologous recombination repair
      Yangyang Kong, Chang Xu, Xiaohui Sun, Hao Sun, Xiaotong Zhao, Ningning He, Kaihua Ji, Qin Wang, Liqing Du, Jinhan Wang, Manman Zhang, Yang Liu, Yan Wang and Qiang Liu
      Cancer Biology & Medicine August 2022, 19 (8) 1150-1171; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0178

  19. Liu, Weidong

    1. Effects of Helicobacter pylori eradication on the profiles of blood metabolites and their associations with the progression of gastric lesions: a prospective follow-up study
      Wenhui Wu, Zongchao Liu, Zhexuan Li, Weidong Liu, Lanfu Zhang, Yang Zhang, Tong Zhou, Weicheng You, Kaifeng Pan and Wenqing Li
      Cancer Biology & Medicine August 2022, 19 (8) 1259-1273; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0255

  20. Liu, Yang

    1. BLM helicase inhibition synergizes with PARP inhibition to improve the radiosensitivity of olaparib resistant non-small cell lung cancer cells by inhibiting homologous recombination repair
      Yangyang Kong, Chang Xu, Xiaohui Sun, Hao Sun, Xiaotong Zhao, Ningning He, Kaihua Ji, Qin Wang, Liqing Du, Jinhan Wang, Manman Zhang, Yang Liu, Yan Wang and Qiang Liu
      Cancer Biology & Medicine August 2022, 19 (8) 1150-1171; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0178

  21. Liu, Zongchao

    1. Effects of Helicobacter pylori eradication on the profiles of blood metabolites and their associations with the progression of gastric lesions: a prospective follow-up study
      Wenhui Wu, Zongchao Liu, Zhexuan Li, Weidong Liu, Lanfu Zhang, Yang Zhang, Tong Zhou, Weicheng You, Kaifeng Pan and Wenqing Li
      Cancer Biology & Medicine August 2022, 19 (8) 1259-1273; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0255

  22. Lu, Zhihao

    1. Alterations in DNA damage response and repair genes as potential biomarkers for immune checkpoint blockade in gastrointestinal cancer
      Yujiao Wang, Xi Jiao, Shuang Li, Huan Chen, Xin Wei, Chang Liu, Jifang Gong, Xiaotian Zhang, Xicheng Wang, Zhi Peng, Changsong Qi, Zhenghang Wang, Yanni Wang, Na Zhuo, Jianling Zou, Henghui Zhang, Jian Li, Lin Shen and Zhihao Lu
      Cancer Biology & Medicine August 2022, 19 (8) 1139-1149; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0708

M

  1. Meng, Zhaoting

    1. Peripheral blood indices to predict PFS/OS with anlotinib as a subsequent treatment in advanced small-cell lung cancer
      Cuicui Zhang, Jing Wang, Xinyue Wang, Zhaoting Meng, Ying Cheng and Kai Li
      Cancer Biology & Medicine August 2022, 19 (8) 1249-1258; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0727

N

  1. Na, Feifei

    1. Epigenetic reprogramming in small cell lung cancer
      Jingyao Chen, Xiangyu Pan, Feifei Na, Xuelan Chen and Chong Chen
      Cancer Biology & Medicine August 2022, 19 (8) 1111-1116; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0343

  2. Nan, Fajun

    1. The HDAC inhibitor GCJ-490A suppresses c-Met expression through IKKα and overcomes gefitinib resistance in non-small cell lung cancer
      Ting He, Yinglei Gao, Yanfen Fang, Yangming Zhang, Shuwei Zhang, Fajun Nan, Jian Ding and Yi Chen
      Cancer Biology & Medicine August 2022, 19 (8) 1172-1192; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0130

  3. Nie, Xiu

    1. Lynch syndrome pre-screening and comprehensive characterization in a multi-center large cohort of Chinese patients with colorectal cancer
      Yan Li, Lihong Fan, Jianming Zheng, Xiu Nie, Yu Sun, Qin Feng, Shenyi Lian, Wenqi Bai, Weijing Cai, Yanan Yang, Bo Su, Yanfeng Xi and Dongmei Lin
      Cancer Biology & Medicine August 2022, 19 (8) 1235-1248; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0585

P

  1. Pan, Kaifeng

    1. Effects of Helicobacter pylori eradication on the profiles of blood metabolites and their associations with the progression of gastric lesions: a prospective follow-up study
      Wenhui Wu, Zongchao Liu, Zhexuan Li, Weidong Liu, Lanfu Zhang, Yang Zhang, Tong Zhou, Weicheng You, Kaifeng Pan and Wenqing Li
      Cancer Biology & Medicine August 2022, 19 (8) 1259-1273; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0255

  2. Pan, Xiangyu

    1. Epigenetic reprogramming in small cell lung cancer
      Jingyao Chen, Xiangyu Pan, Feifei Na, Xuelan Chen and Chong Chen
      Cancer Biology & Medicine August 2022, 19 (8) 1111-1116; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0343

  3. Pan, Yuan

    1. Prospective study of the effect of ERAS on postoperative recovery and complications in patients with gastric cancer
      Ye Tian, Qiang Li and Yuan Pan
      Cancer Biology & Medicine August 2022, 19 (8) 1274-1281; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0108

  4. Peng, Ji

    1. Current cancer burden in China: epidemiology, etiology, and prevention
      Maomao Cao, He Li, Dianqin Sun, Siyi He, Xinxin Yan, Fan Yang, Shaoli Zhang, Changfa Xia, Lin Lei, Ji Peng and Wanqing Chen
      Cancer Biology & Medicine August 2022, 19 (8) 1121-1138; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0231

  5. Peng, Shirong

    1. Loss of NEIL3 activates radiotherapy resistance in the progression of prostate cancer
      Qiong Wang, Zean Li, Jin Yang, Shirong Peng, Qianghua Zhou, Kai Yao, Wenli Cai, Zhongqiu Xie, Fujun Qin, Hui Li, Xu Chen, Kaiwen Li and Hai Huang
      Cancer Biology & Medicine August 2022, 19 (8) 1193-1210; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0550

  6. Peng, Zhi

    1. Alterations in DNA damage response and repair genes as potential biomarkers for immune checkpoint blockade in gastrointestinal cancer
      Yujiao Wang, Xi Jiao, Shuang Li, Huan Chen, Xin Wei, Chang Liu, Jifang Gong, Xiaotian Zhang, Xicheng Wang, Zhi Peng, Changsong Qi, Zhenghang Wang, Yanni Wang, Na Zhuo, Jianling Zou, Henghui Zhang, Jian Li, Lin Shen and Zhihao Lu
      Cancer Biology & Medicine August 2022, 19 (8) 1139-1149; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0708

Q

  1. Qi, Changsong

    1. Alterations in DNA damage response and repair genes as potential biomarkers for immune checkpoint blockade in gastrointestinal cancer
      Yujiao Wang, Xi Jiao, Shuang Li, Huan Chen, Xin Wei, Chang Liu, Jifang Gong, Xiaotian Zhang, Xicheng Wang, Zhi Peng, Changsong Qi, Zhenghang Wang, Yanni Wang, Na Zhuo, Jianling Zou, Henghui Zhang, Jian Li, Lin Shen and Zhihao Lu
      Cancer Biology & Medicine August 2022, 19 (8) 1139-1149; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0708

  2. Qin, Fujun

    1. Loss of NEIL3 activates radiotherapy resistance in the progression of prostate cancer
      Qiong Wang, Zean Li, Jin Yang, Shirong Peng, Qianghua Zhou, Kai Yao, Wenli Cai, Zhongqiu Xie, Fujun Qin, Hui Li, Xu Chen, Kaiwen Li and Hai Huang
      Cancer Biology & Medicine August 2022, 19 (8) 1193-1210; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0550

  3. Qiu, Minghan

    1. Update on diffuse large B-cell lymphoma: highlights from the 2022 ASCO Annual Meeting
      Minghan Qiu, Shan Wu, Xinrui Chen and Huaqing Wang
      Cancer Biology & Medicine August 2022, 19 (8) 1117-1120; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0403

S

  1. Sang, Lei

    1. PYK2 mediates the BRAF inhibitor (vermurafenib)-induced invadopodia formation and metastasis in melanomas
      Junling Shen, Jilong Yang, Lei Sang, Rui Sun, Weiyu Bai, Chao Wang, Yan Sun and Jianwei Sun
      Cancer Biology & Medicine August 2022, 19 (8) 1211-1223; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0294

  2. Shen, Junling

    1. PYK2 mediates the BRAF inhibitor (vermurafenib)-induced invadopodia formation and metastasis in melanomas
      Junling Shen, Jilong Yang, Lei Sang, Rui Sun, Weiyu Bai, Chao Wang, Yan Sun and Jianwei Sun
      Cancer Biology & Medicine August 2022, 19 (8) 1211-1223; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0294

  3. Shen, Lin

    1. Alterations in DNA damage response and repair genes as potential biomarkers for immune checkpoint blockade in gastrointestinal cancer
      Yujiao Wang, Xi Jiao, Shuang Li, Huan Chen, Xin Wei, Chang Liu, Jifang Gong, Xiaotian Zhang, Xicheng Wang, Zhi Peng, Changsong Qi, Zhenghang Wang, Yanni Wang, Na Zhuo, Jianling Zou, Henghui Zhang, Jian Li, Lin Shen and Zhihao Lu
      Cancer Biology & Medicine August 2022, 19 (8) 1139-1149; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0708

  4. Shin, Aesun

    1. Frequent low dose alcohol intake increases gastric cancer risk: the Health Examinees-Gem (HEXA-G) study
      Hwi-Won Lee, Dan Huang, Woo-Kyoung Shin, Katherine de la Torre, Minkyo Song, Aesun Shin, Jong-Koo Lee and Daehee Kang
      Cancer Biology & Medicine August 2022, 19 (8) 1224-1234; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0642

  5. Shin, Woo-Kyoung

    1. Frequent low dose alcohol intake increases gastric cancer risk: the Health Examinees-Gem (HEXA-G) study
      Hwi-Won Lee, Dan Huang, Woo-Kyoung Shin, Katherine de la Torre, Minkyo Song, Aesun Shin, Jong-Koo Lee and Daehee Kang
      Cancer Biology & Medicine August 2022, 19 (8) 1224-1234; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0642

  6. Song, Minkyo

    1. Frequent low dose alcohol intake increases gastric cancer risk: the Health Examinees-Gem (HEXA-G) study
      Hwi-Won Lee, Dan Huang, Woo-Kyoung Shin, Katherine de la Torre, Minkyo Song, Aesun Shin, Jong-Koo Lee and Daehee Kang
      Cancer Biology & Medicine August 2022, 19 (8) 1224-1234; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0642

  7. Su, Bo

    1. Lynch syndrome pre-screening and comprehensive characterization in a multi-center large cohort of Chinese patients with colorectal cancer
      Yan Li, Lihong Fan, Jianming Zheng, Xiu Nie, Yu Sun, Qin Feng, Shenyi Lian, Wenqi Bai, Weijing Cai, Yanan Yang, Bo Su, Yanfeng Xi and Dongmei Lin
      Cancer Biology & Medicine August 2022, 19 (8) 1235-1248; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0585

  8. Sun, Dianqin

    1. Current cancer burden in China: epidemiology, etiology, and prevention
      Maomao Cao, He Li, Dianqin Sun, Siyi He, Xinxin Yan, Fan Yang, Shaoli Zhang, Changfa Xia, Lin Lei, Ji Peng and Wanqing Chen
      Cancer Biology & Medicine August 2022, 19 (8) 1121-1138; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0231

  9. Sun, Hao

    1. BLM helicase inhibition synergizes with PARP inhibition to improve the radiosensitivity of olaparib resistant non-small cell lung cancer cells by inhibiting homologous recombination repair
      Yangyang Kong, Chang Xu, Xiaohui Sun, Hao Sun, Xiaotong Zhao, Ningning He, Kaihua Ji, Qin Wang, Liqing Du, Jinhan Wang, Manman Zhang, Yang Liu, Yan Wang and Qiang Liu
      Cancer Biology & Medicine August 2022, 19 (8) 1150-1171; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0178

  10. Sun, Jianwei

    1. PYK2 mediates the BRAF inhibitor (vermurafenib)-induced invadopodia formation and metastasis in melanomas
      Junling Shen, Jilong Yang, Lei Sang, Rui Sun, Weiyu Bai, Chao Wang, Yan Sun and Jianwei Sun
      Cancer Biology & Medicine August 2022, 19 (8) 1211-1223; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0294

  11. Sun, Rui

    1. PYK2 mediates the BRAF inhibitor (vermurafenib)-induced invadopodia formation and metastasis in melanomas
      Junling Shen, Jilong Yang, Lei Sang, Rui Sun, Weiyu Bai, Chao Wang, Yan Sun and Jianwei Sun
      Cancer Biology & Medicine August 2022, 19 (8) 1211-1223; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0294

  12. Sun, Xiaohui

    1. BLM helicase inhibition synergizes with PARP inhibition to improve the radiosensitivity of olaparib resistant non-small cell lung cancer cells by inhibiting homologous recombination repair
      Yangyang Kong, Chang Xu, Xiaohui Sun, Hao Sun, Xiaotong Zhao, Ningning He, Kaihua Ji, Qin Wang, Liqing Du, Jinhan Wang, Manman Zhang, Yang Liu, Yan Wang and Qiang Liu
      Cancer Biology & Medicine August 2022, 19 (8) 1150-1171; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0178

  13. Sun, Yan

    1. PYK2 mediates the BRAF inhibitor (vermurafenib)-induced invadopodia formation and metastasis in melanomas
      Junling Shen, Jilong Yang, Lei Sang, Rui Sun, Weiyu Bai, Chao Wang, Yan Sun and Jianwei Sun
      Cancer Biology & Medicine August 2022, 19 (8) 1211-1223; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0294

  14. Sun, Yu

    1. Lynch syndrome pre-screening and comprehensive characterization in a multi-center large cohort of Chinese patients with colorectal cancer
      Yan Li, Lihong Fan, Jianming Zheng, Xiu Nie, Yu Sun, Qin Feng, Shenyi Lian, Wenqi Bai, Weijing Cai, Yanan Yang, Bo Su, Yanfeng Xi and Dongmei Lin
      Cancer Biology & Medicine August 2022, 19 (8) 1235-1248; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0585

T

  1. Tian, Ye

    1. Prospective study of the effect of ERAS on postoperative recovery and complications in patients with gastric cancer
      Ye Tian, Qiang Li and Yuan Pan
      Cancer Biology & Medicine August 2022, 19 (8) 1274-1281; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0108

W

  1. Wang, Chao

    1. PYK2 mediates the BRAF inhibitor (vermurafenib)-induced invadopodia formation and metastasis in melanomas
      Junling Shen, Jilong Yang, Lei Sang, Rui Sun, Weiyu Bai, Chao Wang, Yan Sun and Jianwei Sun
      Cancer Biology & Medicine August 2022, 19 (8) 1211-1223; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0294

  2. Wang, Huaqing

    1. Update on diffuse large B-cell lymphoma: highlights from the 2022 ASCO Annual Meeting
      Minghan Qiu, Shan Wu, Xinrui Chen and Huaqing Wang
      Cancer Biology & Medicine August 2022, 19 (8) 1117-1120; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0403

  3. Wang, Jing

    1. Peripheral blood indices to predict PFS/OS with anlotinib as a subsequent treatment in advanced small-cell lung cancer
      Cuicui Zhang, Jing Wang, Xinyue Wang, Zhaoting Meng, Ying Cheng and Kai Li
      Cancer Biology & Medicine August 2022, 19 (8) 1249-1258; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0727

  4. Wang, Jinhan

    1. BLM helicase inhibition synergizes with PARP inhibition to improve the radiosensitivity of olaparib resistant non-small cell lung cancer cells by inhibiting homologous recombination repair
      Yangyang Kong, Chang Xu, Xiaohui Sun, Hao Sun, Xiaotong Zhao, Ningning He, Kaihua Ji, Qin Wang, Liqing Du, Jinhan Wang, Manman Zhang, Yang Liu, Yan Wang and Qiang Liu
      Cancer Biology & Medicine August 2022, 19 (8) 1150-1171; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0178

  5. Wang, Qin

    1. BLM helicase inhibition synergizes with PARP inhibition to improve the radiosensitivity of olaparib resistant non-small cell lung cancer cells by inhibiting homologous recombination repair
      Yangyang Kong, Chang Xu, Xiaohui Sun, Hao Sun, Xiaotong Zhao, Ningning He, Kaihua Ji, Qin Wang, Liqing Du, Jinhan Wang, Manman Zhang, Yang Liu, Yan Wang and Qiang Liu
      Cancer Biology & Medicine August 2022, 19 (8) 1150-1171; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0178

  6. Wang, Qiong

    1. Loss of NEIL3 activates radiotherapy resistance in the progression of prostate cancer
      Qiong Wang, Zean Li, Jin Yang, Shirong Peng, Qianghua Zhou, Kai Yao, Wenli Cai, Zhongqiu Xie, Fujun Qin, Hui Li, Xu Chen, Kaiwen Li and Hai Huang
      Cancer Biology & Medicine August 2022, 19 (8) 1193-1210; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0550

  7. Wang, Xicheng

    1. Alterations in DNA damage response and repair genes as potential biomarkers for immune checkpoint blockade in gastrointestinal cancer
      Yujiao Wang, Xi Jiao, Shuang Li, Huan Chen, Xin Wei, Chang Liu, Jifang Gong, Xiaotian Zhang, Xicheng Wang, Zhi Peng, Changsong Qi, Zhenghang Wang, Yanni Wang, Na Zhuo, Jianling Zou, Henghui Zhang, Jian Li, Lin Shen and Zhihao Lu
      Cancer Biology & Medicine August 2022, 19 (8) 1139-1149; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0708

  8. Wang, Xinyue

    1. Peripheral blood indices to predict PFS/OS with anlotinib as a subsequent treatment in advanced small-cell lung cancer
      Cuicui Zhang, Jing Wang, Xinyue Wang, Zhaoting Meng, Ying Cheng and Kai Li
      Cancer Biology & Medicine August 2022, 19 (8) 1249-1258; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0727

  9. Wang, Yan

    1. BLM helicase inhibition synergizes with PARP inhibition to improve the radiosensitivity of olaparib resistant non-small cell lung cancer cells by inhibiting homologous recombination repair
      Yangyang Kong, Chang Xu, Xiaohui Sun, Hao Sun, Xiaotong Zhao, Ningning He, Kaihua Ji, Qin Wang, Liqing Du, Jinhan Wang, Manman Zhang, Yang Liu, Yan Wang and Qiang Liu
      Cancer Biology & Medicine August 2022, 19 (8) 1150-1171; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0178

  10. Wang, Yanni

    1. Alterations in DNA damage response and repair genes as potential biomarkers for immune checkpoint blockade in gastrointestinal cancer
      Yujiao Wang, Xi Jiao, Shuang Li, Huan Chen, Xin Wei, Chang Liu, Jifang Gong, Xiaotian Zhang, Xicheng Wang, Zhi Peng, Changsong Qi, Zhenghang Wang, Yanni Wang, Na Zhuo, Jianling Zou, Henghui Zhang, Jian Li, Lin Shen and Zhihao Lu
      Cancer Biology & Medicine August 2022, 19 (8) 1139-1149; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0708

  11. Wang, Yujiao

    1. Alterations in DNA damage response and repair genes as potential biomarkers for immune checkpoint blockade in gastrointestinal cancer
      Yujiao Wang, Xi Jiao, Shuang Li, Huan Chen, Xin Wei, Chang Liu, Jifang Gong, Xiaotian Zhang, Xicheng Wang, Zhi Peng, Changsong Qi, Zhenghang Wang, Yanni Wang, Na Zhuo, Jianling Zou, Henghui Zhang, Jian Li, Lin Shen and Zhihao Lu
      Cancer Biology & Medicine August 2022, 19 (8) 1139-1149; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0708

  12. Wang, Zhenghang

    1. Alterations in DNA damage response and repair genes as potential biomarkers for immune checkpoint blockade in gastrointestinal cancer
      Yujiao Wang, Xi Jiao, Shuang Li, Huan Chen, Xin Wei, Chang Liu, Jifang Gong, Xiaotian Zhang, Xicheng Wang, Zhi Peng, Changsong Qi, Zhenghang Wang, Yanni Wang, Na Zhuo, Jianling Zou, Henghui Zhang, Jian Li, Lin Shen and Zhihao Lu
      Cancer Biology & Medicine August 2022, 19 (8) 1139-1149; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0708

  13. Wei, Xin

    1. Alterations in DNA damage response and repair genes as potential biomarkers for immune checkpoint blockade in gastrointestinal cancer
      Yujiao Wang, Xi Jiao, Shuang Li, Huan Chen, Xin Wei, Chang Liu, Jifang Gong, Xiaotian Zhang, Xicheng Wang, Zhi Peng, Changsong Qi, Zhenghang Wang, Yanni Wang, Na Zhuo, Jianling Zou, Henghui Zhang, Jian Li, Lin Shen and Zhihao Lu
      Cancer Biology & Medicine August 2022, 19 (8) 1139-1149; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0708

  14. Wu, Shan

    1. Update on diffuse large B-cell lymphoma: highlights from the 2022 ASCO Annual Meeting
      Minghan Qiu, Shan Wu, Xinrui Chen and Huaqing Wang
      Cancer Biology & Medicine August 2022, 19 (8) 1117-1120; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0403

  15. Wu, Wenhui

    1. Effects of Helicobacter pylori eradication on the profiles of blood metabolites and their associations with the progression of gastric lesions: a prospective follow-up study
      Wenhui Wu, Zongchao Liu, Zhexuan Li, Weidong Liu, Lanfu Zhang, Yang Zhang, Tong Zhou, Weicheng You, Kaifeng Pan and Wenqing Li
      Cancer Biology & Medicine August 2022, 19 (8) 1259-1273; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0255

X

  1. Xi, Yanfeng

    1. Lynch syndrome pre-screening and comprehensive characterization in a multi-center large cohort of Chinese patients with colorectal cancer
      Yan Li, Lihong Fan, Jianming Zheng, Xiu Nie, Yu Sun, Qin Feng, Shenyi Lian, Wenqi Bai, Weijing Cai, Yanan Yang, Bo Su, Yanfeng Xi and Dongmei Lin
      Cancer Biology & Medicine August 2022, 19 (8) 1235-1248; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0585

  2. Xia, Changfa

    1. Current cancer burden in China: epidemiology, etiology, and prevention
      Maomao Cao, He Li, Dianqin Sun, Siyi He, Xinxin Yan, Fan Yang, Shaoli Zhang, Changfa Xia, Lin Lei, Ji Peng and Wanqing Chen
      Cancer Biology & Medicine August 2022, 19 (8) 1121-1138; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0231

  3. Xie, Zhongqiu

    1. Loss of NEIL3 activates radiotherapy resistance in the progression of prostate cancer
      Qiong Wang, Zean Li, Jin Yang, Shirong Peng, Qianghua Zhou, Kai Yao, Wenli Cai, Zhongqiu Xie, Fujun Qin, Hui Li, Xu Chen, Kaiwen Li and Hai Huang
      Cancer Biology & Medicine August 2022, 19 (8) 1193-1210; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0550

  4. Xu, Chang

    1. BLM helicase inhibition synergizes with PARP inhibition to improve the radiosensitivity of olaparib resistant non-small cell lung cancer cells by inhibiting homologous recombination repair
      Yangyang Kong, Chang Xu, Xiaohui Sun, Hao Sun, Xiaotong Zhao, Ningning He, Kaihua Ji, Qin Wang, Liqing Du, Jinhan Wang, Manman Zhang, Yang Liu, Yan Wang and Qiang Liu
      Cancer Biology & Medicine August 2022, 19 (8) 1150-1171; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0178

Y

  1. Yan, Xinxin

    1. Current cancer burden in China: epidemiology, etiology, and prevention
      Maomao Cao, He Li, Dianqin Sun, Siyi He, Xinxin Yan, Fan Yang, Shaoli Zhang, Changfa Xia, Lin Lei, Ji Peng and Wanqing Chen
      Cancer Biology & Medicine August 2022, 19 (8) 1121-1138; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0231

  2. Yang, Fan

    1. Current cancer burden in China: epidemiology, etiology, and prevention
      Maomao Cao, He Li, Dianqin Sun, Siyi He, Xinxin Yan, Fan Yang, Shaoli Zhang, Changfa Xia, Lin Lei, Ji Peng and Wanqing Chen
      Cancer Biology & Medicine August 2022, 19 (8) 1121-1138; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0231

  3. Yang, Jilong

    1. PYK2 mediates the BRAF inhibitor (vermurafenib)-induced invadopodia formation and metastasis in melanomas
      Junling Shen, Jilong Yang, Lei Sang, Rui Sun, Weiyu Bai, Chao Wang, Yan Sun and Jianwei Sun
      Cancer Biology & Medicine August 2022, 19 (8) 1211-1223; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0294

  4. Yang, Jin

    1. Loss of NEIL3 activates radiotherapy resistance in the progression of prostate cancer
      Qiong Wang, Zean Li, Jin Yang, Shirong Peng, Qianghua Zhou, Kai Yao, Wenli Cai, Zhongqiu Xie, Fujun Qin, Hui Li, Xu Chen, Kaiwen Li and Hai Huang
      Cancer Biology & Medicine August 2022, 19 (8) 1193-1210; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0550

  5. Yang, Yanan

    1. Lynch syndrome pre-screening and comprehensive characterization in a multi-center large cohort of Chinese patients with colorectal cancer
      Yan Li, Lihong Fan, Jianming Zheng, Xiu Nie, Yu Sun, Qin Feng, Shenyi Lian, Wenqi Bai, Weijing Cai, Yanan Yang, Bo Su, Yanfeng Xi and Dongmei Lin
      Cancer Biology & Medicine August 2022, 19 (8) 1235-1248; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0585

  6. Yao, Kai

    1. Loss of NEIL3 activates radiotherapy resistance in the progression of prostate cancer
      Qiong Wang, Zean Li, Jin Yang, Shirong Peng, Qianghua Zhou, Kai Yao, Wenli Cai, Zhongqiu Xie, Fujun Qin, Hui Li, Xu Chen, Kaiwen Li and Hai Huang
      Cancer Biology & Medicine August 2022, 19 (8) 1193-1210; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0550

  7. You, Weicheng

    1. Effects of Helicobacter pylori eradication on the profiles of blood metabolites and their associations with the progression of gastric lesions: a prospective follow-up study
      Wenhui Wu, Zongchao Liu, Zhexuan Li, Weidong Liu, Lanfu Zhang, Yang Zhang, Tong Zhou, Weicheng You, Kaifeng Pan and Wenqing Li
      Cancer Biology & Medicine August 2022, 19 (8) 1259-1273; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0255

Z

  1. Zhang, Cuicui

    1. Peripheral blood indices to predict PFS/OS with anlotinib as a subsequent treatment in advanced small-cell lung cancer
      Cuicui Zhang, Jing Wang, Xinyue Wang, Zhaoting Meng, Ying Cheng and Kai Li
      Cancer Biology & Medicine August 2022, 19 (8) 1249-1258; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0727

  2. Zhang, Henghui

    1. Alterations in DNA damage response and repair genes as potential biomarkers for immune checkpoint blockade in gastrointestinal cancer
      Yujiao Wang, Xi Jiao, Shuang Li, Huan Chen, Xin Wei, Chang Liu, Jifang Gong, Xiaotian Zhang, Xicheng Wang, Zhi Peng, Changsong Qi, Zhenghang Wang, Yanni Wang, Na Zhuo, Jianling Zou, Henghui Zhang, Jian Li, Lin Shen and Zhihao Lu
      Cancer Biology & Medicine August 2022, 19 (8) 1139-1149; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0708

  3. Zhang, Lanfu

    1. Effects of Helicobacter pylori eradication on the profiles of blood metabolites and their associations with the progression of gastric lesions: a prospective follow-up study
      Wenhui Wu, Zongchao Liu, Zhexuan Li, Weidong Liu, Lanfu Zhang, Yang Zhang, Tong Zhou, Weicheng You, Kaifeng Pan and Wenqing Li
      Cancer Biology & Medicine August 2022, 19 (8) 1259-1273; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0255

  4. Zhang, Manman

    1. BLM helicase inhibition synergizes with PARP inhibition to improve the radiosensitivity of olaparib resistant non-small cell lung cancer cells by inhibiting homologous recombination repair
      Yangyang Kong, Chang Xu, Xiaohui Sun, Hao Sun, Xiaotong Zhao, Ningning He, Kaihua Ji, Qin Wang, Liqing Du, Jinhan Wang, Manman Zhang, Yang Liu, Yan Wang and Qiang Liu
      Cancer Biology & Medicine August 2022, 19 (8) 1150-1171; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0178

  5. Zhang, Shaoli

    1. Current cancer burden in China: epidemiology, etiology, and prevention
      Maomao Cao, He Li, Dianqin Sun, Siyi He, Xinxin Yan, Fan Yang, Shaoli Zhang, Changfa Xia, Lin Lei, Ji Peng and Wanqing Chen
      Cancer Biology & Medicine August 2022, 19 (8) 1121-1138; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0231

  6. Zhang, Shuwei

    1. The HDAC inhibitor GCJ-490A suppresses c-Met expression through IKKα and overcomes gefitinib resistance in non-small cell lung cancer
      Ting He, Yinglei Gao, Yanfen Fang, Yangming Zhang, Shuwei Zhang, Fajun Nan, Jian Ding and Yi Chen
      Cancer Biology & Medicine August 2022, 19 (8) 1172-1192; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0130

  7. Zhang, Xiaotian

    1. Alterations in DNA damage response and repair genes as potential biomarkers for immune checkpoint blockade in gastrointestinal cancer
      Yujiao Wang, Xi Jiao, Shuang Li, Huan Chen, Xin Wei, Chang Liu, Jifang Gong, Xiaotian Zhang, Xicheng Wang, Zhi Peng, Changsong Qi, Zhenghang Wang, Yanni Wang, Na Zhuo, Jianling Zou, Henghui Zhang, Jian Li, Lin Shen and Zhihao Lu
      Cancer Biology & Medicine August 2022, 19 (8) 1139-1149; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0708

  8. Zhang, Yang

    1. Effects of Helicobacter pylori eradication on the profiles of blood metabolites and their associations with the progression of gastric lesions: a prospective follow-up study
      Wenhui Wu, Zongchao Liu, Zhexuan Li, Weidong Liu, Lanfu Zhang, Yang Zhang, Tong Zhou, Weicheng You, Kaifeng Pan and Wenqing Li
      Cancer Biology & Medicine August 2022, 19 (8) 1259-1273; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0255

  9. Zhang, Yangming

    1. The HDAC inhibitor GCJ-490A suppresses c-Met expression through IKKα and overcomes gefitinib resistance in non-small cell lung cancer
      Ting He, Yinglei Gao, Yanfen Fang, Yangming Zhang, Shuwei Zhang, Fajun Nan, Jian Ding and Yi Chen
      Cancer Biology & Medicine August 2022, 19 (8) 1172-1192; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0130

  10. Zhao, Xiaotong

    1. BLM helicase inhibition synergizes with PARP inhibition to improve the radiosensitivity of olaparib resistant non-small cell lung cancer cells by inhibiting homologous recombination repair
      Yangyang Kong, Chang Xu, Xiaohui Sun, Hao Sun, Xiaotong Zhao, Ningning He, Kaihua Ji, Qin Wang, Liqing Du, Jinhan Wang, Manman Zhang, Yang Liu, Yan Wang and Qiang Liu
      Cancer Biology & Medicine August 2022, 19 (8) 1150-1171; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0178

  11. Zheng, Jianming

    1. Lynch syndrome pre-screening and comprehensive characterization in a multi-center large cohort of Chinese patients with colorectal cancer
      Yan Li, Lihong Fan, Jianming Zheng, Xiu Nie, Yu Sun, Qin Feng, Shenyi Lian, Wenqi Bai, Weijing Cai, Yanan Yang, Bo Su, Yanfeng Xi and Dongmei Lin
      Cancer Biology & Medicine August 2022, 19 (8) 1235-1248; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0585

  12. Zhou, Qianghua

    1. Loss of NEIL3 activates radiotherapy resistance in the progression of prostate cancer
      Qiong Wang, Zean Li, Jin Yang, Shirong Peng, Qianghua Zhou, Kai Yao, Wenli Cai, Zhongqiu Xie, Fujun Qin, Hui Li, Xu Chen, Kaiwen Li and Hai Huang
      Cancer Biology & Medicine August 2022, 19 (8) 1193-1210; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0550

  13. Zhou, Tong

    1. Effects of Helicobacter pylori eradication on the profiles of blood metabolites and their associations with the progression of gastric lesions: a prospective follow-up study
      Wenhui Wu, Zongchao Liu, Zhexuan Li, Weidong Liu, Lanfu Zhang, Yang Zhang, Tong Zhou, Weicheng You, Kaifeng Pan and Wenqing Li
      Cancer Biology & Medicine August 2022, 19 (8) 1259-1273; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0255

  14. Zhuo, Na

    1. Alterations in DNA damage response and repair genes as potential biomarkers for immune checkpoint blockade in gastrointestinal cancer
      Yujiao Wang, Xi Jiao, Shuang Li, Huan Chen, Xin Wei, Chang Liu, Jifang Gong, Xiaotian Zhang, Xicheng Wang, Zhi Peng, Changsong Qi, Zhenghang Wang, Yanni Wang, Na Zhuo, Jianling Zou, Henghui Zhang, Jian Li, Lin Shen and Zhihao Lu
      Cancer Biology & Medicine August 2022, 19 (8) 1139-1149; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0708

  15. Zou, Jianling

    1. Alterations in DNA damage response and repair genes as potential biomarkers for immune checkpoint blockade in gastrointestinal cancer
      Yujiao Wang, Xi Jiao, Shuang Li, Huan Chen, Xin Wei, Chang Liu, Jifang Gong, Xiaotian Zhang, Xicheng Wang, Zhi Peng, Changsong Qi, Zhenghang Wang, Yanni Wang, Na Zhuo, Jianling Zou, Henghui Zhang, Jian Li, Lin Shen and Zhihao Lu
      Cancer Biology & Medicine August 2022, 19 (8) 1139-1149; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0708
Back to top

In this issue

Cancer Biology & Medicine: 19 (8)
Cancer Biology & Medicine
Vol. 19, Issue 8
15 Aug 2022

Submit

Sign up for alerts